COMP <GO>
CLVT vs SHAZ // RSI-14 & 200D SMA MOMENTUM
Clarivate Plc (NYSE) VS. SharonAI Holdings Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: CLVT 7
— SHAZ 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CLVT
LAST: $1.72 (-2.27%) • MKT CAP: $1.10B
rsi-technicals
41.1
LAST: $26.17 (-8.08%) • MKT CAP: $937.0M
rsi-technicals
28.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLVT VS. SHAZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLVT | SHAZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.00% | 6.40% | +59.60 | CLVT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.30% | -23.20% | +24.50 | CLVT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 2.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -1.45% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 2.90% | -60.00% | +62.90 | CLVT | /operating-margins <GO> |
| Net Profit Margin | -8.20% | -60.00% | +51.80 | CLVT | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | 180.00% | -184.00 | SHAZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 2.68 | -2.48 | SHAZ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 2/9 | +3.00 | CLVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 41.1 | 28.6 | +12.52 | CLVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.10B | $937.0M | $163.2M | CLVT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLVT REV | SHAZ REV | CLVT GROSS % | SHAZ GROSS % | CLVT FCF | SHAZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.46B | $1.6M | 66.0% | 6.4% | $365.3M | -$13.6M |
| FY 2024 | $2.56B | $438.3K | 66.0% | -50.0% | $357.5M | -$5.2M |
| FY 2023 | $2.63B | — | — | — | $744.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLVT // BETA —
SHAZ // BETA —